Cancer Targeted Technology
3 clinical trials · Sponsor
◉ Watch Cancer Targeted Technology
| Record | Firm | Date |
|---|---|---|
| A Trial of CTT1403 for Metastatic Castration Resistant Prostate Cancer (NCT03822871) | Cancer Targeted Technology | 2019-04-01 |
| CTT1057, a Small Molecular Inhibitor of PSMA, as a Novel Imaging Agent of Neovascularization in Renal Cell Carcinoma (NCT03427476) | Cancer Targeted Technology | 2018-01-01 |
Track Cancer Targeted Technology automatically
Every clearance here is in the API, with alerts when new ones post.